Arcellx is a clinical-stage biopharmaceutical company developing novel, adaptive and controllable cell therapies for the treatment of patients with cancer and autoimmune diseases.
- Year invested 2020
- Investment Stage Early
- Board Members
- Sectors
- Investment Status Current
- Website arcellx.com/company/about
- Company Status IPO/Public (NASDAQ: ACLX)